Literature DB >> 26146048

[Multiple primary liponeurocytoma of the central nervous system].

A N Konovalov1, N A Konovalov1, I N Pronin1, L V Shishkina1, L I Zolotova1, Yu G Yakovlenko1, V A Korolishin1, R A Onoprienko1, S Yu Timonin1.   

Abstract

We report a unique case of primary multiple liponeurocytoma. Liponeurocytoma is a rare benign tumor (Grade II) of the posterior cranial fossa with neural- or probably astrocytic-lineage cells; the tumor stroma contains mature adipocytes. This case is the thirty-eighth case of this pathology reported in the world literature and the first case of multiple form of this disease. We have provided a sufficiently thorough neuroradiological and histological picture that allows one to differentiate between a liponeurocytoma and other histological variants. Recommendations for the tactics for managing patients with this rare disease are proposed based on the analysis of treatment of this pathology reported in the world literature.

Entities:  

Mesh:

Year:  2015        PMID: 26146048     DOI: 10.17116/neiro201579287-96

Source DB:  PubMed          Journal:  Zh Vopr Neirokhir Im N N Burdenko        ISSN: 0042-8817


  3 in total

1.  Surgical management and clinical outcomes of cerebellar liponeurocytomas-a report of seven cases and a pooled analysis of individual patient data.

Authors:  Pengcheng Zuo; Tao Sun; Guocan Gu; Xiaoou Li; Zhuang Jiang; Changcun Pan; Cheng Xu; Zhen Wu; Junting Zhang; Liwei Zhang
Journal:  Neurosurg Rev       Date:  2022-01-04       Impact factor: 3.042

Review 2.  Recurrent liponeurocytoma: A case report and systematic review of the literature.

Authors:  Darsh S Shah; Himanshu Sharma; Prem Patel; Arya Shetty; Collin William English; J Clay Goodman; Ashwin Viswanathan; Akash J Patel
Journal:  Surg Neurol Int       Date:  2022-09-02

3.  Radiological and Clinical Findings of Multiple Cerebellar Liponeurocytoma: A Case Report.

Authors:  Shan Wang; Xiaopei Xu; Chao Wang
Journal:  Front Surg       Date:  2021-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.